1. Home
  2. ABCL vs EYE Comparison

ABCL vs EYE Comparison

Compare ABCL & EYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • EYE
  • Stock Information
  • Founded
  • ABCL 2012
  • EYE 1990
  • Country
  • ABCL Canada
  • EYE United States
  • Employees
  • ABCL N/A
  • EYE N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • EYE Ophthalmic Goods
  • Sector
  • ABCL Health Care
  • EYE Health Care
  • Exchange
  • ABCL Nasdaq
  • EYE Nasdaq
  • Market Cap
  • ABCL 818.2M
  • EYE 830.0M
  • IPO Year
  • ABCL 2020
  • EYE 2017
  • Fundamental
  • Price
  • ABCL $3.03
  • EYE $11.70
  • Analyst Decision
  • ABCL Buy
  • EYE Hold
  • Analyst Count
  • ABCL 3
  • EYE 5
  • Target Price
  • ABCL $8.00
  • EYE $13.40
  • AVG Volume (30 Days)
  • ABCL 3.9M
  • EYE 1.2M
  • Earning Date
  • ABCL 02-27-2025
  • EYE 02-26-2025
  • Dividend Yield
  • ABCL N/A
  • EYE N/A
  • EPS Growth
  • ABCL N/A
  • EYE N/A
  • EPS
  • ABCL N/A
  • EYE N/A
  • Revenue
  • ABCL $32,962,000.00
  • EYE $2,177,092,000.00
  • Revenue This Year
  • ABCL N/A
  • EYE N/A
  • Revenue Next Year
  • ABCL $37.26
  • EYE $2.86
  • P/E Ratio
  • ABCL N/A
  • EYE N/A
  • Revenue Growth
  • ABCL N/A
  • EYE 20.66
  • 52 Week Low
  • ABCL $2.34
  • EYE $9.56
  • 52 Week High
  • ABCL $5.26
  • EYE $24.11
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 45.64
  • EYE 50.81
  • Support Level
  • ABCL $2.88
  • EYE $12.07
  • Resistance Level
  • ABCL $3.60
  • EYE $12.88
  • Average True Range (ATR)
  • ABCL 0.20
  • EYE 0.46
  • MACD
  • ABCL -0.01
  • EYE 0.03
  • Stochastic Oscillator
  • ABCL 20.83
  • EYE 40.18

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

Share on Social Networks: